Centene Corp (CNC) Retains Buy Rating at Bernstein After Earnings Momentum
Bernstein kept its Buy rating and $79 price target for Centene following strong third-quarter earnings. The insurer continues to show operational turnaround across its core government and commercial healthcare lines.
Centene Corporation remains on a positive trajectory as Bernstein reaffirmed its Buy rating and $79 price target on November 4, according to a report from Futu News cited by ad-hoc-news.de. Analyst Lance Wilkes maintained the constructive outlook on the managed-care company, giving investors an unchanged target for the US-listed shares.
The reaffirmation followed Centene's third-quarter 2026 financial report delivered on Oct. 27, 2026. The company posted adjusted diluted earnings per share of $0.58, which Zacks noted significantly surpassed its consensus forecast of $0.07 while revenue topped consensus estimates by 7.63%. Management pointed to stabilizing medical costs and administrative spending discipline for the profit turnaround.
Chief Executive Officer Sarah London reported during the earnings call that the Medicare Advantage division reached breakeven results in 2026, a full year ahead of initial projections. London also noted progress on state Medicaid reimbursement alignment. In the commercial individual marketplace, Executive Vice President and Chief Financial Officer Drew Asher reported pre-tax margins reached the top of the firm's 4.5% to 5% target range for 2026.
The stock has seen volatile trading alongside its multi-month climb. According to GuruFocus, shares fell 6.0% to $69.74 on November 06, 2026, within a 52-week band of $31.63 to $78.08, though it had touched a fresh peak of $77.05 a session earlier. GuruFocus calculated a GF Value estimate of $75.85, calling the stock 8.1% undervalued, but highlighted $14.6 million in insider share sales with zero purchases over the prior 12 months.
Centene's full-year outlook has also lifted broader analyst estimates. Zacks research indicated consensus expectations of $5.26 in per-share earnings on $199.96 in revenue for the current fiscal year, reflecting a 152.88% boost in earnings. For the next fiscal year, analysts tracked by Zacks anticipate earnings of $5.55 per share on $195.95 in revenue.